US2001A
(en)
*
|
|
1841-03-12 |
|
Sawmill |
US2215233A
(en)
|
1937-11-13 |
1940-09-17 |
Simon L Ruskin |
Iron compound of nucleotides and their organic hydrolytic decomposition products and method of making same
|
US3906092A
(en)
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
US3911117A
(en)
|
1971-12-20 |
1975-10-07 |
Fredrik Ender |
Raw fish and iron chelated with glutamic or ribonucleic acid in a mink diet
|
US3914450A
(en)
|
1973-04-09 |
1975-10-21 |
Anheuser Busch |
Concentrated extract of yeast and processes of making same
|
US4469863A
(en)
|
1980-11-12 |
1984-09-04 |
Ts O Paul O P |
Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
|
WO1983001451A1
(en)
|
1981-10-23 |
1983-04-28 |
Molecular Biosystems Inc |
Oligonucleotide therapeutic agent and methods of making same
|
US5023243A
(en)
|
1981-10-23 |
1991-06-11 |
Molecular Biosystems, Inc. |
Oligonucleotide therapeutic agent and method of making same
|
ES507187A0
(es)
|
1981-11-16 |
1983-01-01 |
Union Ind Y Agro Ganader S A U |
Procedimiento de obtencion de una leche humanizada adiciona-da de nucleotidos con destino a la alimentacion infantil.
|
JPS60126220A
(ja)
|
1983-12-09 |
1985-07-05 |
Otsuka Pharmaceut Factory Inc |
核酸成分組成物
|
US4741914A
(en)
|
1984-11-13 |
1988-05-03 |
Ajinomoto Co., Inc. |
Flavor enhancing seasoning containing deodorized garlic extract and process
|
US4956296A
(en)
|
1987-06-19 |
1990-09-11 |
Genex Corporation |
Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
|
JPS62275667A
(ja)
|
1986-05-22 |
1987-11-30 |
Ajinomoto Co Inc |
こく味調味料又はこく味の増強された食品の製造法
|
EP0291980B1
(de)
|
1987-05-20 |
1992-01-02 |
Chugai Seiyaku Kabushiki Kaisha |
Salzersatz und dieses enthaltende Nahrungsmittel
|
ES2007350A6
(es)
|
1987-05-29 |
1989-06-16 |
Ganadera Union Ind Agro |
Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
|
JP2656571B2
(ja)
*
|
1987-11-17 |
1997-09-24 |
三井東圧化学株式会社 |
テトラフェニルチオフェン誘導体およびこれを含有する電子写真用感光体
|
US5268365A
(en)
|
1988-03-11 |
1993-12-07 |
Rudolph Frederick B |
Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
|
CA1336174C
(en)
|
1988-07-22 |
1995-07-04 |
Ronald Peter Potman |
Method for the preparation of a yeast extract said yeast extract, its use as a food flavour and a food composition comprising the yeast extract
|
US5231085A
(en)
|
1988-10-31 |
1993-07-27 |
Sandoz Ltd. |
Compositions and methods for the enhancement of host defense mechanisms
|
US5786189A
(en)
|
1989-11-29 |
1998-07-28 |
Smithkline Beecham Biologicals (S.A.) |
Vaccine
|
US5514577A
(en)
|
1990-02-26 |
1996-05-07 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide therapies for modulating the effects of herpes viruses
|
US5248670A
(en)
|
1990-02-26 |
1993-09-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides for inhibiting herpesviruses
|
EP0468520A3
(en)
|
1990-07-27 |
1992-07-01 |
Mitsui Toatsu Chemicals, Inc. |
Immunostimulatory remedies containing palindromic dna sequences
|
US5234811A
(en)
|
1991-09-27 |
1993-08-10 |
The Scripps Research Institute |
Assay for a new gaucher disease mutation
|
EP0580754A1
(de)
|
1991-04-18 |
1994-02-02 |
The Salk Institute For Biological Studies |
Oligodeoxynukleotide und oligonukleotide, verwendbar als köder für proteine, die ausgewählt zu definierten dns-sequenzen binden
|
US6022853A
(en)
|
1991-08-30 |
2000-02-08 |
Creative Biomolecules, Inc. |
Morphogen-enriched dietary composition
|
AU3628193A
(en)
|
1992-02-18 |
1993-09-13 |
Gesellschaft Fur Biotechnologische Forschung Mbh |
Dysentery vaccine stimulating an immune response against shigatoxin, plasmids and host strains for it
|
ATE260971T1
(de)
|
1992-04-01 |
2004-03-15 |
Univ Rockefeller |
Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
|
EP0572735B1
(de)
|
1992-06-04 |
1998-11-25 |
VYSIS, Inc. |
Nukleinsäuresonden zum Nachweis von Mycoplasma fermentans
|
US5585479A
(en)
|
1992-07-24 |
1996-12-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Antisense oligonucleotides directed against human ELAM-I RNA
|
JPH08504570A
(ja)
|
1992-10-05 |
1996-05-21 |
ハイブライドン インコーポレイテッド |
治療用抗hivオリゴヌクレオチドと薬剤
|
US5650156A
(en)
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
WO1995001097A1
(en)
|
1993-06-30 |
1995-01-12 |
Board Of Regents, The University Of Texas System |
Nucleotide preparation and uses thereof in wound healing
|
US5849719A
(en)
|
1993-08-26 |
1998-12-15 |
The Regents Of The University Of California |
Method for treating allergic lung disease
|
US5804566A
(en)
|
1993-08-26 |
1998-09-08 |
The Regents Of The University Of California |
Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
|
GB9326425D0
(en)
|
1993-12-24 |
1994-02-23 |
Secr Defence |
Vaccine compositions
|
US5602109A
(en)
|
1994-01-10 |
1997-02-11 |
Abbott Laboratories |
Method to enhance the immune system of a human
|
US5492899A
(en)
|
1994-01-10 |
1996-02-20 |
Abbott Laboratories |
Infant nutritional formula with ribo-nucleotides
|
US5700590A
(en)
|
1994-01-10 |
1997-12-23 |
Abbott Laboratories |
Nutritional formula with ribo-nucleotides
|
US5488039A
(en)
|
1994-01-10 |
1996-01-30 |
Abbott Laboratories |
Method for the production of an enteral formula containing ribo-nucleotides
|
EP0672354B1
(de)
|
1994-03-18 |
2000-07-12 |
Ajinomoto Co., Inc. |
Proteinhaltiges Mittel zur Verbesserung der Geschmacksqualität von Lebensmitteln
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
EP1167379A3
(de)
|
1994-07-15 |
2004-09-08 |
University Of Iowa Research Foundation |
Immunomodulatorische Oligonukleotide
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5591721A
(en)
|
1994-10-25 |
1997-01-07 |
Hybridon, Inc. |
Method of down-regulating gene expression
|
US6428788B1
(en)
|
1995-03-15 |
2002-08-06 |
Penn State University |
Compositions and methods for specifically targeting tumors
|
US5614191A
(en)
|
1995-03-15 |
1997-03-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
IL-13 receptor specific chimeric proteins and uses thereof
|
JP3580900B2
(ja)
|
1995-04-20 |
2004-10-27 |
ホクレン農業協同組合連合会 |
α−グルコシダーゼ阻害剤を含む糖を主体とする組成物を有効成分とする食品及び飼料
|
US5612060A
(en)
|
1995-05-25 |
1997-03-18 |
Alexander; J. Wesley |
Enhancement of transplant graft survival through nutritional immunomodulation and immunosuppressive therapy
|
US5976580A
(en)
|
1995-06-07 |
1999-11-02 |
Novus International, Inc. |
Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
|
GB9525902D0
(en)
|
1995-12-16 |
1996-02-21 |
Zeneca Ltd |
Fungus
|
ATE437943T1
(de)
|
1996-01-30 |
2009-08-15 |
Univ California |
Expressionsvektoren, die eine antigen-spezifische immunantwort induzieren, und methoden für ihre verwendung.
|
US5895652A
(en)
|
1996-07-29 |
1999-04-20 |
Longevity Institute International |
Method of metabolic adjuvanation and cellular repair
|
US5856462A
(en)
|
1996-09-10 |
1999-01-05 |
Hybridon Incorporated |
Oligonucleotides having modified CpG dinucleosides
|
ES2241042T3
(es)
|
1996-10-11 |
2005-10-16 |
The Regents Of The University Of California |
Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora.
|
EP0855184A1
(de)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmazeutisches Präparat das ein Polynukleotid und ein Antigen enthält, insbesondere zur Impfung
|
US6214806B1
(en)
|
1997-02-28 |
2001-04-10 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CPC dinucleotide in the treatment of LPS-associated disorders
|
WO1998040100A1
(en)
*
|
1997-03-10 |
1998-09-17 |
Ottawa Civic Loeb Research Institute |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
US6426334B1
(en)
*
|
1997-04-30 |
2002-07-30 |
Hybridon, Inc. |
Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
|
AU7690898A
(en)
*
|
1997-05-20 |
1998-12-11 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
EP1003850B1
(de)
|
1997-06-06 |
2009-05-27 |
The Regents of the University of California |
Inhibitoren von immunstimulatorischen dna sequenz aktivität
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US5922766A
(en)
|
1997-07-02 |
1999-07-13 |
Acosta; Phyllis J. B. |
Palatable elemental medical food
|
AU757175B2
(en)
|
1997-09-05 |
2003-02-06 |
Regents Of The University Of California, The |
Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
|
AU760549B2
(en)
|
1998-04-03 |
2003-05-15 |
University Of Iowa Research Foundation, The |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
AU3884199A
(en)
*
|
1998-05-06 |
1999-11-23 |
Ottawa Health Research Institute |
Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
|
CN1297481A
(zh)
|
1998-05-06 |
2001-05-30 |
法玛西雅厄普约翰美国公司 |
向非人脊椎动物导入编码非人脊椎动物肽激素或细胞因子的裸dna或rna
|
IL139646A0
(en)
*
|
1998-05-14 |
2002-02-10 |
Coley Pharm Group Inc |
Methods for regulating hematopoiesis using cpg-oligonucleotides
|
SI1077722T1
(sl)
|
1998-05-22 |
2007-02-28 |
Ottawa Health Research Inst |
Metode in produkti za induciranje sluznicne imunosti
|
US7227011B2
(en)
|
1998-06-04 |
2007-06-05 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acid vaccines for prevention of flavivirus infection
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
JP2002521489A
(ja)
|
1998-07-27 |
2002-07-16 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
CpGオリゴヌクレオチドの立体異性体および関連する方法
|
US20010034330A1
(en)
|
1998-08-10 |
2001-10-25 |
Charlotte Kensil |
Innate immunity-stimulating compositions of CpG and saponin and methods thereof
|
US20020065236A1
(en)
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
DK1832657T3
(da)
|
1998-09-09 |
2012-12-17 |
Genzyme Corp |
Methylering af plasmid-vektorer
|
US20020142974A1
(en)
|
1998-09-11 |
2002-10-03 |
Leonard D. Kohn |
Immune activation by double-stranded polynucleotides
|
EP1119375A4
(de)
|
1998-10-05 |
2005-02-02 |
Regetns Of The University Of C |
Verfahren und adjuvantien für die stimulierung von mukosaler immunität
|
WO2000021556A1
(en)
|
1998-10-09 |
2000-04-20 |
Dynavax Technologies Corporation |
Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens
|
CA2359636A1
(en)
|
1999-01-22 |
2000-07-27 |
Andrew W. Taylor |
Activation of regulatory t cells by alpha-melanocyte stimulating hormone
|
US6977245B2
(en)
*
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
AU4343700A
(en)
|
1999-04-12 |
2000-11-14 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Oligodeoxynucleotide and its use to induce an immune response
|
WO2000062787A1
(en)
|
1999-04-15 |
2000-10-26 |
The Regents Of The University Of California |
Methods and compositions for use in potentiating antigen presentation by antigen presenting cells
|
WO2000067023A1
(en)
|
1999-04-29 |
2000-11-09 |
Coley Pharmaceutical Gmbh |
Screening for immunostimulatory dna functional modifyers
|
ES2250151T3
(es)
|
1999-06-29 |
2006-04-16 |
Glaxosmithkline Biologicals S.A. |
Uso de cpg como adyuvante de vacuna contra vih.
|
US6514948B1
(en)
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
DE60041335D1
(de)
|
1999-08-19 |
2009-02-26 |
Dynavax Tech Corp |
Methode zur modulierung eines immunantwortes mit immunstimulierenden sequencen und zusammensetzungen dafür
|
CN1454091A
(zh)
*
|
1999-09-25 |
2003-11-05 |
衣阿华大学研究基金会 |
免疫刺激性核酸
|
WO2001022990A2
(en)
|
1999-09-27 |
2001-04-05 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
US6949520B1
(en)
*
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
US20020091095A1
(en)
|
1999-12-13 |
2002-07-11 |
Phillips Nigel C. |
Modulation of Fas and FasL expression
|
US20020006403A1
(en)
|
1999-12-14 |
2002-01-17 |
Xue-Zhong Yu |
CD28-specific antibody compositions for use in methods of immunosuppression
|
EP1322655B1
(de)
*
|
2000-01-14 |
2007-11-14 |
The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services |
Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
|
US20010044416A1
(en)
|
2000-01-20 |
2001-11-22 |
Mccluskie Michael J. |
Immunostimulatory nucleic acids for inducing a Th2 immune response
|
AT409085B
(de)
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
US6552006B2
(en)
|
2000-01-31 |
2003-04-22 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
AU4175101A
(en)
|
2000-02-23 |
2001-09-03 |
Univ California |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
JP2003523398A
(ja)
|
2000-02-24 |
2003-08-05 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
樹状細胞のインビボ活性化によるアジュバント治療
|
US20020156033A1
(en)
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
US20020098199A1
(en)
|
2000-03-10 |
2002-07-25 |
Gary Van Nest |
Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
|
US20020028784A1
(en)
|
2000-03-10 |
2002-03-07 |
Nest Gary Van |
Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
|
US20020107212A1
(en)
|
2000-03-10 |
2002-08-08 |
Nest Gary Van |
Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
US7157437B2
(en)
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
US20010046967A1
(en)
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
EP1267618A1
(de)
|
2000-03-28 |
2003-01-02 |
The Regents Of The University Of California |
Verfahren zur erhöhung einer zytotoxischen t lymphozyten-reaktion in vivo
|
AU2001251407A1
(en)
|
2000-04-07 |
2001-10-23 |
The Regents Of The University Of California |
Synergistic improvements to polynucleotide vaccines
|
AU2001275294A1
(en)
*
|
2000-06-07 |
2001-12-17 |
Biosynexus Incorporated. |
Immunostimulatory RNA/DNA hybrid molecules
|
US20020165178A1
(en)
|
2000-06-28 |
2002-11-07 |
Christian Schetter |
Immunostimulatory nucleic acids for the treatment of anemia, thrombocytopenia, and neutropenia
|
AU2001280883A1
(en)
|
2000-07-27 |
2002-02-13 |
The Children's Hospital & Research Center At Oakland |
Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
|
US20020198165A1
(en)
|
2000-08-01 |
2002-12-26 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of gastric ulcers
|
US7811592B2
(en)
|
2000-08-16 |
2010-10-12 |
Auburn University |
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
|
US20020091097A1
(en)
|
2000-09-07 |
2002-07-11 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of sexually transmitted diseases
|
ES2298269T3
(es)
|
2000-09-26 |
2008-05-16 |
Idera Pharmaceuticals, Inc. |
Modulacion de la actividad inmunoestimulante de analogos oligonucleotidicos inmunoestimulantes mediante cambios quimicos posicionales.
|
JP2004509914A
(ja)
|
2000-09-28 |
2004-04-02 |
カイロン コーポレイション |
微粒子組成物およびその製造方法
|
AU2002228932A1
(en)
|
2000-10-24 |
2002-05-06 |
Schering Corporation |
Maturation of dendritic cells
|
KR100331952B1
(ko)
|
2000-11-23 |
2002-04-09 |
최수일 |
다목적 고기능성 알칼리 용액 조성물 및 그 제조방법과 비특이 면역증강제로서의 용도
|
US7666674B2
(en)
*
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
WO2003020884A2
(en)
*
|
2001-08-14 |
2003-03-13 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services |
Method for rapid generation of mature dendritic cells
|
AU2002366710A1
(en)
*
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
US8043622B2
(en)
*
|
2002-10-08 |
2011-10-25 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
|
JP4976653B2
(ja)
*
|
2002-11-01 |
2012-07-18 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシス |
免疫刺激性CpGオリゴヌクレオチドを用いてバイオテロ病原体による感染症を予防する方法
|
WO2006063152A2
(en)
*
|
2004-12-08 |
2006-06-15 |
3M Innovative Properties Company |
Immunostimulatory combinations and methods
|
WO2006065751A2
(en)
*
|
2004-12-13 |
2006-06-22 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
|
WO2007027718A1
(en)
*
|
2005-08-31 |
2007-03-08 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods of altering an immune response induced by cpg oligodeoxynucleotides
|
US8053422B2
(en)
*
|
2008-12-04 |
2011-11-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-cancer oligodeoxynucleotides
|